Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Lung Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    June 2025
  1. YUAN Q, Li X, Chen X, Xiao J, et al
    7?Difluoromethoxyl?5,4'?di?n?octylygenistein targets the STAT3 pathway by upregulating microRNA?152?3p expression to inhibit self?renewal and tumor growth in non?small cell lung carcinoma.
    Oncol Rep. 2025;53:66.
    PubMed     Abstract available


    May 2025
  2. HU Y, Liu X, Yuan Z, He J, et al
    Induction of necroptosis in lung adenocarcinoma by miR?10b?5p through modulation of the PKP3/RIPK3/MLKL cascade.
    Oncol Rep. 2025;53:56.
    PubMed     Abstract available


  3. LIN GB, Chen WT, Kuo YY, Liu HH, et al
    Thermal cycling?hyperthermia sensitizes non?small cell lung cancer A549 cells to EGFR tyrosine kinase inhibitor erlotinib.
    Oncol Rep. 2025;53:58.
    PubMed     Abstract available


  4. ZHANG J, Qi S, Du Y, Dai H, et al
    Effect of quercetin on inhibiting gefitinib?activated non?small cell lung cancer?induced cell pyroptosis in cardiomyocytes via modulating mitochondrial autophagy mediated by the SHP2/ROS/AMPK/XBP?1/DJ?1 signaling pathway.
    Oncol Rep. 2025;53:57.
    PubMed     Abstract available


    April 2025
  5. ZHANG L, Wang S, Wang L
    Pan?cancer analysis of oncogene SFXN1 to identify its prognostic and immunological roles in lung adenocarcinoma.
    Oncol Rep. 2025;53:50.
    PubMed     Abstract available


    February 2025
  6. PENG Y, Li D, Wampfler JA, Luo YH, et al
    Targeted therapy?associated cardiotoxicity in patients with stage?IV lung cancer with or without cardiac comorbidities.
    Oncol Rep. 2025;53:25.
    PubMed     Abstract available


  7. ZHOU S, Sun J, Zhu W, Yang Z, et al
    Hypoxia studies in non?small cell lung cancer: Pathogenesis and clinical implications (Review).
    Oncol Rep. 2025;53:29.
    PubMed     Abstract available


    January 2025
  8. MUTO S, Homma MK, Kiko Y, Ozaki Y, et al
    Nucleolar casein kinase 2 alpha as a prognostic factor in patients with surgically resected early?stage lung adenocarcinoma.
    Oncol Rep. 2025;53:4.
    PubMed     Abstract available


  9. WANG M, Chen X, Fu G, Ge M, et al
    [Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS?mutated lung cancer cells.
    Oncol Rep. 2025;53:1.
    PubMed     Abstract available


    December 2024
  10. WEI Q, Lin J, Lin Z, Yu N, et al
    GOLPH3 inhibition overcomes cisplatin resistance by restoring the glutathione/reactive oxygen species balance in the A549 non?small cell lung cancer cell line.
    Oncol Rep. 2024;52:170.
    PubMed     Abstract available


  11. HU X, Zhang S, Zhang X, Liu H, et al
    HOXD1 inhibits lung adenocarcinoma progression and is regulated by DNA methylation.
    Oncol Rep. 2024;52:173.
    PubMed     Abstract available


    November 2024
  12. GUI H, Nie Y, Yuan H, Jing Q, et al
    The combination of a PTP1B inhibitor, TNFR2 blocker, and PD?1 antibody suppresses the progression of non?small cell lung cancer tumors by enhancing immunocompetence.
    Oncol Rep. 2024;52:149.
    PubMed     Abstract available


  13. KANAYAMA M, Yoneda K, Kuwata T, Mori M, et al
    Enhanced capture system for mesenchymal?type circulating tumor cells using a polymeric microfluidic device 'CTC?Chip' incorporating cell?surface vimentin.
    Oncol Rep. 2024;52:156.
    PubMed     Abstract available


  14. GEORGAKOPOULOU VE, Lempesis IG, Trakas N, Sklapani P, et al
    Lung cancer and obesity: A contentious relationship (Review).
    Oncol Rep. 2024;52:158.
    PubMed     Abstract available


    October 2024
  15. ZHOU M, Wei L, Lu R
    Emerging role of sirtuins in non?small cell lung cancer (Review).
    Oncol Rep. 2024;52:127.
    PubMed     Abstract available


  16. WEI W, Zhao X, Zhu J, Zhang L, et al
    [Retracted] lncRNA?u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
    Oncol Rep. 2024;52:126.
    PubMed     Abstract available


  17. MUNKHJARGAL B, Kondo K, Soejima S, Tegshee B, et al
    DNA methylation and mRNA expression of ZNF577 as biomarkers for the detection and prognosis of lung adenocarcinoma.
    Oncol Rep. 2024;52:131.
    PubMed     Abstract available


    August 2024
  18. LI S, Wang H, Ma R, Wang L, et al
    [Retracted] Schisandrin B inhibits epithelial?mesenchymal transition and stemness of large?cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF?kappaB and p38 MAPK signaling pathways.
    Oncol Rep. 2024;52:102.
    PubMed     Abstract available


    July 2024
  19. CHENG SH, Tu KY, Lee HH
    The dynamic duo: A narrative review on the synergy between stereotactic body radiotherapy and immunotherapy in lung cancer treatment (Review).
    Oncol Rep. 2024;52:96.
    PubMed     Abstract available


    June 2024
  20. GAO Y, Zhang G, Liu J, Li H, et al
    [Retracted] Tissue?specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA?125a?5p in lung cancer.
    Oncol Rep. 2024;51:76.
    PubMed     Abstract available


    February 2024
  21. ZHANG F, Qi Y, Li J, Liu B, et al
    Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway.
    Oncol Rep. 2024;51:29.
    PubMed     Abstract available


  22. LU X, Ma S, Li Y, Pan Y, et al
    Identification of ITGB4 as a novel tumor promoting gene in lung adenocarcinoma (LUAD).
    Oncol Rep. 2024;51:30.
    PubMed     Abstract available


  23. LOU H, Wu Z, Wei G
    CDC6 may serve as an indicator of lung adenocarcinoma prognosis and progression based on TCGA and GEO data mining and experimental analyses.
    Oncol Rep. 2024;51:35.
    PubMed     Abstract available


    January 2024
  24. CHENG Z, Cui H, Wang Y, Yang J, et al
    The advance of the third?generation EGFR?TKI in the treatment of non?small cell lung cancer (Review).
    Oncol Rep. 2024;51:16.
    PubMed     Abstract available


    December 2023
  25. LIU J, Zhang F, Wang J, Wang Y, et al
    MicroRNA?mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).
    Oncol Rep. 2023;50:211.
    PubMed     Abstract available


    November 2023
  26. CHEN Z, Li P, Shen L, Jiang X, et al
    Heat shock protein B7 (HSPB7) inhibits lung adenocarcinoma progression by inhibiting glycolysis.
    Oncol Rep. 2023;50:196.
    PubMed     Abstract available


  27. WU Z, Liu S, Pang G, Jiang H, et al
    RNA?binding protein quaking 5 inhibits the progression of non?small cell lung cancer by upregulating netrin?4 expression.
    Oncol Rep. 2023;50:204.
    PubMed     Abstract available


  28. TIAN C, Li J, Ren L, Peng R, et al
    [Retracted] MicroRNA?381 serves as a prognostic factor and inhibits migration and invasion in non?small cell lung cancer by targeting LRH?1.
    Oncol Rep. 2023;50:203.
    PubMed     Abstract available


  29. ZHANG J, Darman L, Hassan MS, Von Holzen U, et al
    Targeting KRAS for the potential treatment of pancreatic ductal adenocarcinoma: Recent advancements provide hope (Review).
    Oncol Rep. 2023;50:206.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.